RIDAQUICK Gliadin - approved by AOAC

RIDAQUICK Gliadin - approved by AOAC

Agricultural Sciences / Nutrition & Food Sciences / Agro-Food

November 09, 2017

R-biopharm is proud to announce that lateral flow test for gluten analysis is now approved by one of the most important organizations for method validation. The dip stick RIDA®QUICK Gliadin was approved by the AOAC Performance Tested Methods (SM) Program and was assigned PTM Certification No. 101702 by the AOAC Research Institute.

The results of the validation were carried out by an independent lab and demonstrated that the dipstick is applicable for the detection of traces of gliadin on environmental surfaces (stainless steel, sealed ceramic, plastic and silicone rubber) and in clean-in-place waters.

The RIDA®QUICK Gliadin test kit was also evaluated in an international collaborative study for food. The immunochromatographic test is an AACC international approved method (38-60.01) and an AOAC approved Official Method of Analysis (Final Action OMA 2015.16).

The limit of detection was evaluated for the following matrices:

  • surfaces approx. 1.6 - 3 µg gluten / 100 cm2
  • raw material approx. 4.4 mg/kg gluten
  • processed food approx. 6.3 mg/kg gluten
  • cleansing water (without cleansing reagent) approx. 10 ng/ml gluten
  • cleaning water (with cleansing reagent) approx. 50 - 100 ng/ml gluten
More safety and better results - benefit from modernized USP methods!

More safety and better results - benefit from modernized USP methods!

Agricultural Sciences / Nutrition & Food Sciences ...

Metrohm together with USP have started updating numerous wet chemistry methods for pharmaceutical analysis. This newsletter presents some recently modernized methods including an optimized titration method and a new IC method for zinc oxide assay. 

September 24, 2018 More +
Enrich and detect CTCs of prostate cancer from blood

Enrich and detect CTCs of prostate cancer from blood

Agricultural Sciences / Nutrition & Food Sciences ...

Circulating tumor cells (CTCs) constitute a useful approach for personalized medicine. In prostate cancer, the expression of three tumor-associated transcripts, prostate-specific membrane antigen (PSMA), prostate-specific antigen (PSA) and epidermal growth factor receptor (EGFR), are often altered and used as biomarkers.

March 01, 2017 More +
Ready to make an enquiry Call us on: + 961 1 39 66 77
Or email us